Ten Important Considerations for Ovarian Cancer Screening - Test2 - elhamkhani - TriplyDB

Ten Important Considerations for Ovarian Cancer Screening

Ten Important Considerations for Ovarian Cancer Screening

http://www.wikidata.org/entity/Q33850463

about

Ovarian Cancer Screening: Lessons about Effectiveness.

P2860

Q48332409-EB140109-16BD-4A51-9165-F3D7CAB1B7A4

P2860

Ten Important Considerations for Ovarian Cancer Screening

http://www.wikidata.org/entity/Q33850463

description

2017 nî lūn-bûn

@nan

2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Ten Important Considerations for Ovarian Cancer Screening

@ast

Ten Important Considerations for Ovarian Cancer Screening

@en

type

label

Ten Important Considerations for Ovarian Cancer Screening

@ast

Ten Important Considerations for Ovarian Cancer Screening

@en

prefLabel

Ten Important Considerations for Ovarian Cancer Screening

@ast

Ten Important Considerations for Ovarian Cancer Screening

@en

P1433

Q33850463-6687D7C9-D957-4C19-A04F-CEDD1597CBEA

P1476

Q33850463-AAE2FBEC-8A30-45D4-89EE-66B03C1CB4B2

P2093

Q33850463-E74873C0-156B-4E13-8707-DB383F0BA444

P2860

Q33850463-0DD904D1-549F-4EC2-AE71-BAFC8F7F27CC

Q33850463-0FE1229D-EFD7-487F-B966-2719341FB179

Q33850463-11D6302D-81AB-448F-9F8F-E913B47AF107

Q33850463-14AE0961-F8DD-44D8-BA79-DF818154A03F

Q33850463-18149341-2B0D-4345-94AA-B1117E99030E

Q33850463-1E5C656B-467A-4976-8656-904DC55D46F4

Q33850463-20904C85-37A7-44EF-8177-9591C83B038B

Q33850463-23BB6A76-5CEC-4E5A-9E34-A1AEA3140D1A

Q33850463-2DB95672-20F1-4CA0-AFB0-FAFC61F0D896

Q33850463-2FEE1DAF-5100-48D9-AB49-94087A82F4BC

P31

Q33850463-5EF2E8FC-6E34-42FB-9844-63E7EAFE6F5E

P356

Q33850463-C06F065D-7C53-4412-8B20-2E5A1FF18095

P433

Q33850463-44AE2E28-465B-4464-8F81-2B754EA18024

P478

Q33850463-F27FC748-1E6C-4A91-B0D7-14416DB80F3E

P50

Q33850463-D80FA1EA-A260-495B-A29E-769531E45251

P577

Q33850463-A477066B-BD95-4729-825E-C66CFA2D9E50

P698

Q33850463-00C56C8F-0DF2-46F3-9391-3CAD5330A770

P921

Q33850463-C666820F-AF37-4F86-9BCD-DDDD54025F3E

P932

Q33850463-BB1FA667-6E4F-4257-B384-54635D6F6EBD

P356

DIAGNOSTICS7020022

P1433

Diagnostics (Basel, Switzerland)

P1476

Ten Important Considerations for Ovarian Cancer Screening

@en

P2093

Edward J Pavlik

http://www.w3.org/2001/XMLSchema#string

P2860

Why most published research findings are false

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Effect of Screening on Ovarian Cancer Mortality

Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Impact of National Cancer Institute Comprehensive Cancer Centers on ovarian cancer treatment and survival.

Ovarian cancer in the United States: contemporary patterns of care associated with improved survival.

P31

scholarly article

P356

10.3390/DIAGNOSTICS7020022

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Edward J Pavlik

P577

2017-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28406427

http://www.w3.org/2001/XMLSchema#string

P921

P932

5489942

http://www.w3.org/2001/XMLSchema#string